"0002-5562-60" National Drug Code (NDC)

NDC Code	0002-5562-60
Package Description	60 TABLET, COATED in 1 BOTTLE (0002-5562-60)
Product NDC	0002-5562
Product Type Name	HUMAN PRESCRIPTION DRUG
Proprietary Name	Retevmo
Non-Proprietary Name	Selpercatinib
Dosage Form	TABLET, COATED
Usage	ORAL
Start Marketing Date	20240410
Marketing Category Name	NDA
Application Number	NDA218160
Manufacturer	Eli Lilly and Company
Substance Name	SELPERCATINIB
Strength	160
Strength Unit	mg/1
Pharmacy Classes	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Rearranged during Transfection (RET) Inhibitors [MoA]